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Cortical thickness: An early morphological marker of athero- frequent in patients with diffuse atherosclerotic disease
sclerotic renal disease. [1, 2]. One important issue is related to the detection of
Background. Although kidney size is still the most commonly ARD because the clinical symptoms often appear late,used morphological parameter, it is not sensitive enough for
and there is no current diagnostic test that is sufficientlyearly detection of atherosclerotic renal disease (ARD). The pur-
sensitive to disclose the pathology [1, 3]. Furthermore,pose of this work was to evaluate morphological abnormalities
on both post-stenotic and controlateral kidneys, by using spiral there are no clinical, biological, morphological or func-
computed tomography angiography (CTA). tional markers that demonstrate a causal relationship
Methods. Spiral CTA was performed in 49 hypertensive pa- between a stenosis and the deterioration of renal func-tients. Renal diameters, renal length, and cortical thickness were
tion, or that could be used to assess renal viability [1, 3].measured in 26 post-stenotic kidneys, 26 contralateral kidneys
There are no specific clinical symptoms of the atheroscle-and 46 control kidneys. Mean cortical thickness, cortical area,
and medullary length were calculated. rotic renal disease [1, 4–6]. The diagnosis by way of “pre-
Results. The right and left control kidneys were of compara- sumption” is based upon combining several suggestive
ble morphology. The post-stenotic kidneys showed significant
clinical and biological criteria that most often arise incortical atrophy. The controlateral kidneys also underwent cor-
one of eleven typical clinical situations regarded as beingtical disease, as judged by comparison with control kidneys. A
threshold of 800 mm2 was identified for the cortical area that al- at risk [1–3, 5, 6].
lowed us to distinguish control kidneys from post-stenotic kid- The purpose of this work was to evaluate renal mor-
neys. Similarly, a threshold of 8 mm was identified for mean phological abnormalities in hypertensive patients withcortical thickness. Renal length was still within normal range in
unilateral atherosclerotic stenosis by using spiral com-all kidney groups. The measurement of superior pole segments
puted tomography angiography (CTA).appeared to be more sensitive than measurement at other
locations for identifying significant intrarenal lesions. There
was no significant correlation between clinical and morphologi-
cal parameters. METHODS
Conclusions. These results suggest that cortical parameters are
Populationmore sensitive for early diagnosis of ARD than kidney size.
Cortical atrophy should be a useful marker for guidance for Between November 1995 and July 1997, 76 hyperten-
revascularization. sive patients bearing a strong history suggestive of reno-
vascular disease [4] were studied consecutively in order
to assess the distal consequences of unilateral athero-
Atherosclerotic renal disease (ARD) has numerous sclerotic renal artery stenosis. Others causes of secondary
etiologies including proximal arterial atherosclerotic ste- hypertension and cortical atrophy, such as reflux ne-
noses and intraparenchymal arterial lesions [1–3]. A grow- phropathy, prior stone passage with intermittent hydro-
ing cause of chronic renal failure, this pathology is more nephrosis, previous pyelonephritis, and hypoplatic kid-
neys, were excluded. To further homogenize our patient
cohort, this work did not take into account bilateralKey words: renal artery stenosis, atrophy, hypertension, intrarenal le-
sions, revascularization, arterial lesions. atherosclerotic renal artery stenosis (RAS; 16 cases),
atherosclerotic RAS in a single kidney (5 cases), associ-Received for publication February 1, 2001
ated polycystic kidney disease (1 case), and fibromuscu-and in revised form September 17, 2001
Accepted for publication September 18, 2001 lar RAS (5 cases). As a result, 49 patients were included
in the current study. 2002 by the International Society of Nephrology
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Systolic blood pressure (SBP) and diastolic blood pres- Cortical area (CA), mean cortical thickness (MCT)
and medullar length (ML) were calculated as follows:sure (DBP) were measured with the patient in the supine
position, in accordance with the Recommendations of the
MCT (mm)  (AST  LST  PST  AIT
World Health Organization (WHO). Pulse blood pres-
sure (PBP) was defined as the difference between SBP  LIT  PIT)/6
and DBP. Hypertension was defined as SBP 140 mm Hg
CA (mm2)  (RL x MCT)
and/or DBP  90 mm Hg. Heart rate was measured on
the resting electrocardiogram. The other demographic data ML (mm)  RL  [(AST  LST  PST)/3
included age, gender, history of arterial hypertension2
 (AIT  LIT  PIT)/3]
years, smoking habits, family history in terms of cardio-
vascular disease, body mass index (BMI) [weight (kg)/ The reproducibility and the agreement of these mea-
surements were assessed during a preliminary phase us-length (m2)], diabetes mellitus, and dyslipidemia. Serum
potassium and serum creatinine levels also were mea- ing the methods of Fermanian and Fleiss [12, 13]. Briefly,
the reproducibility and the agreement of the measure-sured. Creatinine clearance was calculated on the basis
of the Cockcroft-Gault formula as follows: ments were respectively R2  0.53 to 0.93 and R2  0.73
to 0.94 for the renal length and the postero-lateral thick-140  age (years)  weight (kg)]
serum creatinine (mg/L)  K
ness. Conversely, the antero-superior thickness measure-
ments varied considerably (R  0.40 to 0.45) [14].
where K  7.2 for men and K  8.5 for women. In this study, the term “atrophy” refers to a statisti-
In preparation for angiography and spiral CTA, a cally significant reduction in renal length, cortical thick-
nephroprotection protocol was performed in all cases, ness, and medullary length as compared with the control
combining hydration (intravenous saline 500 mL on the kidney group. We previously performed several studies
day of the examination), and calcium antagonist treat- that demonstrated very satisfactory levels of specificity
ment (felodipine 10 mg on the day before the examina- (96%) and sensitivity (100%) arising from combining
tion, the day of the examination and the following day) Doppler ultrasonography with spiral CTA for the RAS
[7, 8]. diagnosis [9–11]. Consequently, for ethical considera-
tions, we did not perform renal arteriography in 23 of
Spiral computed tomography angiography 49 patients, in whom both spiral CTA and Doppler ultra-
Spiral CTA (Somaton plus 4A; Siemens, Erlanger, sonography were normal. As a result, these patients were
Germany) and Doppler ultrasonography (128 XP; Acu- considered as “essential” hypertensives.
son, Mountain View, CA, USA) were systematically
Digital renal arteriographyperformed as previously described [9–11].
The acquisition spiral CTA protocol has been de- Digital subtraction angiography (Integris V 3000; Phil-
scribed elsewhere [10]. A total of 120 to 150 mL of con- ips, Best, Netherlands) was performed in only 26 of 49
trast material (300 mg of iodine/mL; Telebrix 30, meg- patients who were suspected to have atherosclerotic
lumine ioxithalamate; Guerbet, Villepinte, France) was RAS on spiral CTA or on Doppler ultrasonography. A
injected during the procedure. The spiral CTA protocol total of 50 to 120 mL of iodinated contrast material
was non-contingent upon age and weight. Twelve mor- (Hexabrix; Guerbet) was injected.
phological parameters were studied for each kidney. We The stenoses were considered to be significant when
assumed that the width of the dense peripheral band they reduced the arterial lumen by more than 50%, rep-
was equivalent to the cortical width. This band was mea- resenting a reduction of 70% of the cross-sectional
sured in each of nine regions to assess anteroposterior area. The renal vasculature obtained by arteriography
diameter (APD), transverse diameter (TD), renal length was comparable to that obtained with spiral CTA.
(RL), and 6 cortical thicknesses: anterosuperior (AST),
Evaluation criteria and statistical analysislaterosuperior (LST), posterosuperior (PST), antero-
inferior (AIT), lateroinferior (LIT), and posteroinferior The population of 49 hypertensive patients was divided
(PIT). Renal length was referred to as the difference into two groups depending on the presence or absence of
between the first section that showed the superior pole atherosclerotic RAS. Patients with no RAS formed a
of the kidney, and the first section that showed the infe- first group [Group 1: “Control Group” of 23 essential
rior pole of the kidney. Renal diameters were measured hypertensive patients, who therefore had 46 control kid-
on a section cut at the midpoint of these two sections. neys (“C Kidney Group”)]. Patients with unilateral RAS
Superior cortical thicknesses were studied two centi- formed a second group [Group 2: 26 patients, that is, 26
meters below the superior pole of the kidney, and in- kidneys with RAS (“S Kidney Group”), and 26 contralat-
ferior cortical thicknesses two centimeters above the eral (or opposite) kidneys (“OPP Kidney Group”)]. The
12 morphological parameters were compared betweeninferior pole of the kidney.
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Table 1. Demographic characteristics of the two groups of difference of 23 mL/min between Group 1 and Group 2
hypertensive patients
(P  0.0007), but we also had to take into account the
Group 1 Group 2 negative correlation existing between creatinine clear-
(N23) (N26) P value ance and age (r  0.63; P  0.0001) when interpreting
Male/female, N 11/12 13/13 NS these results. DBP was lower (P 0.03) and PBP higher
Age years 5213 6011 0.02
(P  0.01) in Group 2. SBP was higher in Group 2, butHistory of hypertension
2 years, N (%) 14 (60.9) 17 (65.4) NS this result was not significant. Mean differences in SBP
Cigarette smoking, and PBP between Group 1 and Group 2 were 6 mm Hg
N (%) 5 (21.7) 13 (50.0) 0.04
and 15 mm Hg, respectively. Smoking was more commonDiabetes mellitus,
N (%) 6 (26.1) 5 (19.2) NS in Group 2 patients (P  0.04). Group 1 and Group 2
Dyslipidemia, N (%) 17 (73.9) 18 (69.2) NS were comparable in terms of history of hypertension,
Family history of
family history of cardiovascular disease, sex ratio, bodycardiovascular
disease, N (%) 6 (26.1) 15 (57.7) NS mass index, and prevalence of diabetes mellitus. Al-
HR beats/minute 779 719 0.02 though there were several demographic differences be-
SBP mm Hg 16815 17421 NS
tween Group 1 and Group 2, no clinical or biologicalDBP mm Hg 10114 9212 0.03
PBP mm Hg 6615 8120 0.01 variable could identify the patients who suffered from
Body mass index kg/m2 285 253 NS RAS, because the distribution of these variables was
Creatinine clearance
comparable in both groups. Severe hypertension wasmL/min 8819 6522 0.0007
Kalemia mmol/L 3.90.4 3.80.4 NS the most common clinical presentation of renal artery
stenosis (22 patients out of 26), followed by acute pulmo-Definitions are: Group 1, “essential” hypertensive patients, that is, the “con-
trol” group; Group 2, hypertensive patients displaying unilateral renal artery nary edema (2 patients) and renal failure after initiation
stenosis. Results are shown as mean standard deviation for numerical parame-
of angiotensin converting enzyme inhibitor treatment (2ters and frequency and percentage for categorical parameters. Abbreviations
are: N, number of patients; HR, heart rate; SBP, systolic blood pressure; DBP, patients). There were 14 moderate stenoses (50 to 70%)
diastolic blood pressure; PBP, pulsed blood pressure.
and 12 severe stenoses (75 to 90%).
The morphological characteristics of each group of
kidneys (C Kidney Group, OPP Kidney Group and
S Kidney Group) are listed in Tables 2 and 3. Therethe C Kidney Group, the S Kidney Group, and the OPP
were no significant morphological differences betweenKidney Group. We also determined whether the location
the left and right-sided control kidneys (Fig. 1).of the control kidneys (right or left side) had an effect
Opposite kidneys (OPP Group 2) and C kidneyson the parameters studied. The demographic parameters
(Group 1) were of comparable length. Conversely, S kid-were compared between Group 1 and Group 2 in order
neys (Group 2) were significantly smaller than C kidneysto identify clinical variables potentially associated with
(P 0.03) and OPP kidneys (P 0.0019). The transversethe presence of RAS.
and the APD diameters were comparable in C, OPP andThe statistical analysis yielded a descriptive analysis
S kidneys. Compared to C kidneys, OPP kidneys had aof the population, a study of Spearman’s coefficients in
thinner cortex that reached the superior and inferiororder to correlate the clinical and the morphological
poles, except for the AIT section (Fig. 2). Mean corticalparameters, and a two factor non-parametric analysis of
thickness and cortical area were significantly altered invariance (ANOVA). The threshold values for the corti-
Group 2 (respectively OPP vs. C kidneys’ MCT, P cal area and the mean cortical thickness were outlined
0.0014; S vs. C kidneys’ MCT, P  0.0001; Fig. 3; OPPby an ROC curve analysis that provided the best separa-
vs. C kidneys’ CA, P  0.01; S vs. C kidneys’ CA, P tion of the post-stenotic kidneys from the control kid-
0.0001). In the same group, mean cortical thickness andneys. A Kruskal-Wallis test was used to compare the
cortical area were different between S and OPP kidneysmean cortical thickness among C kidneys, OPP kidneys,
(OPP vs. S kidneys’ extracellular matrix (ECM), P and S kidneys. The threshold significance level (risk )
0.0015; OPP vs. S kidneys’ CA, P  0.0002). Using thewas set at 5%. The data analysis was performed with
receiver operating characteristic (ROC) curve analysis,SAS software (SAS version 8.1; SAS Institute Inc., Cary,
the threshold value was set at 800 mm2 for the corticalNC, USA).
area in order to differentiate post-stenotic kidneys from
control kidneys with 85% sensitivity, 89% specificity,
RESULTS 91% negative predictive value, and 81% positive pre-
The demographic characteristics of Group 1 and dictive value (Table 4). From a second ROC curve, the
Group 2 are set out in Table 1. Group 2 patients were threshold value was set at 8 mm for the mean cortical
significantly older than those of Group 1 (P  0.02) thickness in order to distinguish post-stenotic kidneys
with a mean age difference of eight years. Creatinine from control kidneys with 73% sensitivity, 93% specific-
ity, 86% negative predictive value, and 86% positiveclearance was lower in patients with RAS, with a mean
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Table 2. Results of the 12 morphological parameters in both groups of patients
Group 1 (N23) Group 2 (N26)
Right C kidneys Left C kidneys OPP kidneys S kidneys
(N23) (N23) (N26) (N26)
Renal length mm 10411 10111 10014 9114
Transverse diameter mm 526 516 516 507
Anteroposterior diameter mm 518 526 537 498
Anterosuperior cortical thickness mm 9.11.0 9.51.3 8.01.7 7.12.1
Laterosuperior cortical thickness mm 8.61.3 9.11.4 7.41.8 6.12.3
Posterosuperior cortical thickness mm 8.91.1 8.91.4 7.52.2 6.72.1
Anteroinferior cortical thickness mm 9.00.7 8.71.3 8.01.8 6.11.8
Lateroinferior cortical thickness mm 9.70.7 9.51.1 8.31.9 6.72.4
Posteroinferior cortical thickness mm 9.30.7 9.21.1 8.21.6 6.91.8
Mean cortical thickness mm 9.10.6 9.21.0 7.91.4 6.61.6
Cortical area mm2 950119 934157 806210 612193
Medulla length mm 8511 8311 8413 7714
Definitions are: Group 1, “essential” hypertensive patients, the “control” group; Group 2, hypertensive patients displaying unilateral renal artery stenosis; C
kidneys, groups of “right side” and “left side” control kidneys; OPP kidneys, group of contralateral non-stenotic kidneys; S kidneys, group of post-stenotic kidneys.
Results are shown as mean  standard deviation.
Table 3. Morphological differences between C kidneys, OPP kidneys, and S kidneys: Comparison of means two by two
Right vs. left C kidneys vs. C kidneys vs. OPP kidneys vs.
C kidneys OPP kidneys S kidneys S kidneys
Antero-posterior diameter NS NS NS NS
Transverse diameter NS NS NS NS
Renal length NS NS 0.03 0.0019
Anterosuperior cortical thickness NS 0.02 0.0001 NS
Posterosuperior cortical thickness NS 0.03 0.0001 NS
Laterosuperior cortical thickness NS 0.02 0.0001 0.04
Anteroinferior cortical thickness NS NS 0.0001 0.0003
Posteroinferior cortical thickness NS 0.0029 0.0001 0.01
Lateroinferior cortical thickness NS 0.009 0.0001 0.0077
Mean cortical thickness NS 0.0014 0.0001 0.0015
Cortical area NS 0.01 0.0001 0.0002
Medulla length NS NS NS 0.0079
Abbreviations are: C kidneys, control kidneys; OPP kidneys, contralateral non-stenotic kidneys; S kidneys, post-stenotic kidneys. Results are shown as the P value.
Results are significant if P 	 0.05.
predictive value (Table 5). Medullary length was compa- eral RAS, the controlateral kidneys also underwent sig-
nificant parenchymal disease, as judged by comparisonrable between C and OPP kidneys. Medullary length
with control kidneys. Measurement of the superior polewas significantly lower in the S kidney compared to the
segments appeared to be more sensitive than measure-OPP kidney group (P 0.0079). The correlation study of
ment at other locations for assessing significant reno-the twelve morphological parameters in Group 1 showed
vascular disease.that the cortical area and the medullary length were
The size of a “normal” kidney is variable from onecorrelated (r  0.53; P  0.0001). Renal length was
person to another, decreasing after age 70 [15]. The nor-positively correlated to medullary length (r  0.95; P 
mal values usually cited are 110 20 mm [15], the kidney0.0001) and to cortical area (r  0.73; P  0.0001). The
being considered “small” if it is below 80 mm [16]. Sev-study of Spearman’s coefficients of correlation showed
eral studies have shown that reduced kidney size is corre-that no morphological parameters were contingent upon
lated to the significant and evolving nature of the stenosisage, gender, weight, history of hypertension, risk factors
[1, 16–18]. Asymmetry in kidney size tends to indicatefor atherosclerosis, blood pressure level, or creatinine
a renovascular etiology, especially when associated withclearance.
chronic renal failure, hypertension or low-grade protein-
uria [1, 2, 4, 5]. Our results indirectly confirmed these
DISCUSSION data because post-stenotic kidneys that appeared smaller
The major finding of this study was that cortical thick- than control kidneys all displayed anatomically signifi-
ness, especially CA and MCT, was a good morphological cant lesions. The preserved size of contralateral kidneys
without stenosis led to the same conclusion. However,marker for the diagnosis of ARD. In the case of unilat-
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Fig. 1. Spiral computed tomography angiography (CTA)
image sections of two control kidneys in an essential hyper-
tensive patient. Both kidneys (A, right superior pole; B, left
superior pole) display a mean cortical thickness greater than
the 8-mm threshold (refer to the measurement scale located
to the right of each panel where each increment corresponds
to 10 mm).
although more sensitive than serum creatinine [18], the studying the renal cortex, based on calculating a mean
cortical index and taking into account the upper (calleddecrease in size is a late marker in ARD, because it
reflects the presence of lesions that are already mature “superior” in our study), mean and lower (called “infe-
rior” in our study) cortical thicknesses [17]. Our study[1, 2, 17, 18]. These data demonstrated the need for
identifying other more sensitive markers of ARD. The analyzed the superior and inferior poles separately,
based upon measuring 6 cortical thicknesses of the ante-study of cortical thickness meets these objectives. Prince,
Schoenberg and Ward suggested a global method of rior, posterior and lateral regions.
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Fig. 2. Spiral CTA image sections in a hypertensive patient
displaying a significant renal artery stenosis. (A) Transverse
axial section of the superior pole of the right post-stenotic
kidney. The anterior, the lateral and the posterior cortical
thicknesses show diffuse cortical damage. The cortical thick-
ness values are 6 to 7 mm on average, according to the mea-
surement scale located on the reproduction where each in-
crement corresponds to 10 mm. (B) Transverse axial section
of the superior pole of the left contralateral non-stenotic
kidney. The cortical thicknesses were greater than the 8-mm
threshold on average, referring to the same scale.
Our study revealed greater vulnerability of the supe- less sensitive for early detection of ARD. The study of
the cortical area, also called “nephronic mass” [17], wasrior pole of the kidney to ischemia, the AIT cortical
thickness of contralateral kidneys being comparable to interesting since we identified a threshold of 800 mm2
that allowed us to distinguish control kidneys from post-that of the control kidneys. Thus, the measurement of
superior cortical thicknesses appeared to be more sensi- stenotic kidneys. Similarly, we identified a threshold of
8 mm for mean cortical thickness. Calculation of meantive than the inferior location for the diagnosis of isch-
emic renal parenchymal damage. An overall evaluation cortical thickness is easier for routine application than
that of cortical area.of the renal cortex, as performed by Prince et al [17], is
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Table 5. Sensitivity, specificity, positive and negative predictive
values of the threshold value of the mean cortical thickness set
at 8 mm as a means of identifying the post-stenotic kidney
Confidence interval 95%
MCT threshold set at 8 mm N (%) upper limit–lower limit %
Sensitivity 19/26 (73) 52–88
Specificity 43/46 (93) 82–99
PPV 19/22 (86) 65–97
NPV 43/50 (86) 73–94
Abbreviations are: MCT, mean cortical thickness; PPV, positive predictive
value; NPV, negative predictive value.
These phenomen that might be considered as regula-
tory mechanisms to protect the post-stenotic kidney per-
fusion [23] are in fact deleterious to both kidneys [1–3,
17, 23]. The different type of vascularization between theFig. 3. Comparison of mean cortical thickness between the three
cortex and the medulla, as well as the redistribution ofgroups of kidneys: control (C kidneys), contralateral (OPP kidneys),
and post-stenotic (S kidneys). blood flow from the cortex to the medulla due to hypo-
perfusion, could explain early cortical atrophy [6, 17,
24, 25]. Structural arteriolar lesions, induced by long-
standing hypertension, and distal cholesterol emboli areTable 4. Sensitivity, specificity, positive and negative predictive
values of the threshold value of the cortical area set at 800 mm2 often associated [1–3, 5, 6, 19, 20].
as a means of identifying the post-stenotic kidney Although there were significant differences in creati-
nine clearance, age and morphological parameters betweenCA threshold set Confidence interval 95%
at 800 mm2 N (%) upper limit–lower limit % the two groups of patients, we observed no significant
Sensitivity 22/26 (85) 65–96 relationship between kidney function and morphological
Specificity 41/46 (89) 76–96 changes. The small size of our study population could
PPV 22/27 (81) 61–94
partly explain these results.NPV 41/45 (91) 79–98
The main reason for early diagnosis of ARD is theAbbreviations are: CA, cortical area; PPV, positive predictive value; NPV,
negative predictive value. hope that correction of RAS will lead to an improvement
in renal function or delay the progression to end-stage
renal disease by preserving the functional nephronic
mass [3, 6]. Textor has argued that a sizeable number of
We suggest that cortical thickness parameters are good patients affected with severe renal artery stenoses retain
markers for the diagnosis of ARD, considering that they stable renal function over the years and do not necessar-
occur earlier than the reduction of kidney size. The mea- ily require revascularization, with its attending risks of
surement of cortical thickness also revealed significant complications, including cholesterol crystal embolism
lesions in contralateral kidneys without stenosis. Unlike [22]. The cortical parameters, especially the MCT, should
other previous studies [17], we demonstrated that contra- help the clinician recognize when revascularization is
lateral kidneys could not be used as “control” kidneys, indicated. Thus, to identify kidneys beyond salvage, se-
in the sense they may already be displaying the conse- vere cortical atrophy on spiral CTA should indicate sig-
quences of atherosclerotic disease and chronic hyperten- nificant hemodynamic RAS. It would be interesting to
sion [1, 2, 17, 19, 20]. conduct further prospective studies comparable to that
Cortical atrophy alone does not explain the small size of Caps and co-authors [18], using spiral CTA, to provide
of the post-stenotic kidneys. Other elements may be accurate indications as to the progression of renal isch-
involved, particularly when the medullary length is af- emia and its management.
fected, as was the case in our post-stenotic kidney group.
Study limitsMedullary length may reflect more severe renal hypoper-
fusion or indicate a more advanced stage of atheroscle- The results of this study should be interpreted care-
rotic renal disease [21]. Renal atrophy could be a direct fully because of the size of our population. No one can
consequence of renal hypoperfusion [21, 22]. Activation assume whether cortical atrophy is exclusively related to
of the renin-angiotensin system due to hypoperfusion renal hypoperfusion or to specific parenchymal disease
has several deleterious effects, such as inducing tubulo- and/or cholesterol crystal emboli. The values of the mor-
interstitial atrophy [1–3, 22, 23], and renal vascular le- phological parameters in Group 1 cannot be extrapolated
to healthy volunteers, all the more so since 14 of 23 pa-sions (nephrosclerosis) [4, 19–23].
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renal effects of felodipine in hypertensive patients with kidneytients had a history of previous hypertension. The mor-
disease. Kidney Int 41(Suppl 36):S106–S109, 1992
phological parameters were measured under the effect 8. Herlitz H: Long-term effects of felodipine in patients with reduced
renal function. Kidney Int 41(Suppl 36):S110–S113, 1992of a vasodilator (the calcium antagonist felodipine) that
9. Elkohen M, Beregi JP, Deklunder G, et al: Evaluation of spiralmight increase the apparent cortical thickness. The in-
computed tomography of the renal arteries alone or combined with
ferior pole of the kidney was studied by spiral CTA at doppler ultrasonography in the detection of renal artery stenosis.
Prospective study of 114 renal arteries. Arch Mal Coeur 88:1159–a later time, around 25 seconds, than the superior pole.
1164, 1995Consequently, the interpretation of morphological dif-
10. Beregi JP, Elkohen M, Deklunder G, et al: Helical CT angiogra-
ferences between the two poles should take into consid- phy compared with arteriography in the detection of renal artery
stenosis. Am J Roentgenol 167:495–501, 1996eration the spiral CTA protocol. Multidetector CT scan
11. Beregi JP, Louvegny S, Ceugnart L, et al: Helical CT angiographymay solve this methodologic issue. Cortical atrophy is not
of renal arteries: Two-years’ experience. J Radiol 78:549–559, 1997
specific of renovascular disease. Other common causes of 12. Fermanian J: The degree of concordance between observers:
Quantitative case. Rev Epide´m et Sante´ Publ 32:408–413, 1984cortical atrophy may cause the same morphological ap-
13. Fleiss JL: Reliability of measurement, in The Design and Analysispearance. However, in a context of atherosclerotic renal
of Clinical Experiment, edited by Fleiss JL, New York, John Wiley
disease, cortical atrophy should be a useful time saving and Sons, 1986, pp 1–32
14. Mounier-Vehier C, Jaboureck O, Devos P, et al: Me´thodesmarker to assess the distal consequences of a RAS.
d’e´tude de la morphologie re´nale chez le patient hypertendu. Arch
Mal cœur 94:919–924, 2001
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